Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children

Paul S. Lietman, Sheldon L. Kaplan, Edward O. Mason, Sally K. Mason, Francis I. Catlin, Rita T. Lee, Mary Murphy, Ralph D. Feigin

    Research output: Contribution to journalArticlepeer-review

    39 Scopus citations

    Abstract

    In a prospective, randomized study, moxalactam in 44 children was compared with amplicillin or chloramphenicol in 47 children for the treatment of Haemophilus influenzae type b meningitis. Both groups were comparable in terms of clinical and laboratory findings at admission. The hospital course, neurologic sequelae including deafness, and number of deaths were the same for both groups. The incidence of adverse reactions also was the same except that diarrhea and thrombocytosis occurred significantly (P≤0.04) more frequently in children given moxalactam. Moxalactam was equivalent to ampicillin or chloramphenicol in the treatment of H. influenzae type b meningitis in children.

    Original languageEnglish (US)
    Pages (from-to)447-453
    Number of pages7
    JournalThe Journal of Pediatrics
    Volume104
    Issue number3
    DOIs
    StatePublished - Mar 1984

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health

    Fingerprint

    Dive into the research topics of 'Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children'. Together they form a unique fingerprint.

    Cite this